An experimental gene-editing treatment shows promise for permanently lowering levels of cholesterol and triglycerides, ...

Over the next decade, 1.2 billion young people will reach working age in developing countries. Without immediate action, millions of young men and women may be left without a clear path to employment.

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of ...

Emerging biotechnologies, strategic collaborations, and growing focus on personalized and regenerative medicine are accelerating the next wave of gene therapy innovation.Austin, Nov. 05, 2025 (GLOBE ...

The Point-of-Care Molecular Diagnostics Market is experiencing robust expansion driven by rising demand for rapid, accurate, ...

Caribou Biosciences ( ($CRBU) ) has provided an update. On November 3, 2025, Caribou Biosciences announced positive results from its ANTLER phase ...

TG Therapeutics (NASDAQ: TGTX) will release its quarterly earnings report on Monday, 2025-11-03. Here's a brief overview for investors ahead of the announcement. Analysts anticipate TG Therapeutics to ...

Abstract: Due to their large bandwidth, relatively low cost, and robust performance, Ultra-Wideband (UWB) radio chips can be used for a wide variety of applications, including localization, ...

The U.S. Cell and Gene Therapy Clinical Trials Market Leads Global Growth with Robust Biotech Activity, Regulatory Support, and Expanding Late-Stage Pipelines.Austin, Oct. 30, 2025 (GLOBE NEWSWIRE) -- ...

In the realm of food safety, the escalation of antibiotic resistance and the adverse effects of chemical preservatives have driven the search for novel ...

Detailed price information for Crispr Therapeutics Ag (CRSP-Q) from The Globe and Mail including charting and trades.

An increasing demand for gene therapies is focusing the industry on enhancing production capabilities, transitioning from ...